PDF(868 KB)
Cost-effectiveness analysis of lorlatinib versus iruplinalkib in anaplastic lymphoma kinase-positive advanced non-small-cell lung cancer
CHEN Weiwei, HOU Yanhong, YANG Jin, WU Fang, NI Yaqian, LIU Jing, LIU Yuhang
Chinese Journal of Hospital Pharmacy ›› 2026, Vol. 46 ›› Issue (3) : 301-306.
PDF(868 KB)
PDF(868 KB)
Cost-effectiveness analysis of lorlatinib versus iruplinalkib in anaplastic lymphoma kinase-positive advanced non-small-cell lung cancer
({{custom_author.role_en}}), {{javascript:window.custom_author_en_index++;}}| {{custom_ref.label}} |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
/
| 〈 |
|
〉 |
